214 related articles for article (PubMed ID: 28450267)
1. Retinal changes in the Tg-SwDI mouse model of Alzheimer's disease.
Oliveira-Souza FG; DeRamus ML; van Groen T; Lambert AE; Bolding MS; Strang CE
Neuroscience; 2017 Jun; 354():43-53. PubMed ID: 28450267
[TBL] [Abstract][Full Text] [Related]
2. Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease.
Perez SE; Lumayag S; Kovacs B; Mufson EJ; Xu S
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):793-800. PubMed ID: 18791173
[TBL] [Abstract][Full Text] [Related]
3. Investigations into Retinal Pathology in the Early Stages of a Mouse Model of Alzheimer's Disease.
Chidlow G; Wood JP; Manavis J; Finnie J; Casson RJ
J Alzheimers Dis; 2017; 56(2):655-675. PubMed ID: 28035930
[TBL] [Abstract][Full Text] [Related]
4. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Proteolytic Pathways and Altered Protein Biosynthesis Underlie Retinal Pathology in a Mouse Model of Alzheimer's Disease.
Mirzaei M; Pushpitha K; Deng L; Chitranshi N; Gupta V; Rajput R; Mangani AB; Dheer Y; Godinez A; McKay MJ; Kamath K; Pascovici D; Wu JX; Salekdeh GH; Karl T; Haynes PA; Graham SL; Gupta VK
Mol Neurobiol; 2019 Sep; 56(9):6017-6034. PubMed ID: 30707393
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholine receptors in the retinas of the α7 nicotinic acetylcholine receptor knockout mouse.
Smith ML; Souza FG; Bruce KS; Strang CE; Morley BJ; Keyser KT
Mol Vis; 2014; 20():1328-56. PubMed ID: 25352741
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional Remodeling in Primary Hippocampal Astrocytes from an Alzheimer's Disease Mouse Model.
Ruffinatti F; Tapella L; Gregnanin I; Stevano A; Chiorino G; Canonico PL; Distasi C; Genazzani AA; Lim D
Curr Alzheimer Res; 2018; 15(11):986-1004. PubMed ID: 29895250
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment.
Koronyo Y; Salumbides BC; Black KL; Koronyo-Hamaoui M
Neurodegener Dis; 2012; 10(1-4):285-93. PubMed ID: 22343730
[TBL] [Abstract][Full Text] [Related]
10. GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease.
Kamphuis W; Kooijman L; Orre M; Stassen O; Pekny M; Hol EM
Glia; 2015 Jun; 63(6):1036-56. PubMed ID: 25731615
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein-I and -III expression in animal models of Alzheimer disease.
Carrasco J; Adlard P; Cotman C; Quintana A; Penkowa M; Xu F; Van Nostrand WE; Hidalgo J
Neuroscience; 2006 Dec; 143(4):911-22. PubMed ID: 17027170
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease.
Choi SH; Aid S; Caracciolo L; Minami SS; Niikura T; Matsuoka Y; Turner RS; Mattson MP; Bosetti F
J Neurochem; 2013 Jan; 124(1):59-68. PubMed ID: 23083210
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease.
Bedse G; Romano A; Cianci S; Lavecchia AM; Lorenzo P; Elphick MR; Laferla FM; Vendemiale G; Grillo C; Altieri F; Cassano T; Gaetani S
J Alzheimers Dis; 2014; 40(3):701-12. PubMed ID: 24496074
[TBL] [Abstract][Full Text] [Related]
14. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
[TBL] [Abstract][Full Text] [Related]
15. Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer's disease.
Burgaletto C; Platania CBM; Di Benedetto G; Munafò A; Giurdanella G; Federico C; Caltabiano R; Saccone S; Conti F; Bernardini R; Bucolo C; Cantarella G
Cell Death Dis; 2021 Oct; 12(10):905. PubMed ID: 34611142
[TBL] [Abstract][Full Text] [Related]
16. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
[TBL] [Abstract][Full Text] [Related]
17. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
[TBL] [Abstract][Full Text] [Related]
18. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
[TBL] [Abstract][Full Text] [Related]
19. Brain gangliosides of a transgenic mouse model of Alzheimer's disease with deficiency in GD3-synthase: expression of elevated levels of a cholinergic-specific ganglioside, GT1aα.
Ariga T; Itokazu Y; McDonald MP; Hirabayashi Y; Ando S; Yu RK
ASN Neuro; 2013 May; 5(2):141-8. PubMed ID: 23565921
[TBL] [Abstract][Full Text] [Related]
20. Defined astrocytic expression of human amyloid precursor protein in Tg2576 mouse brain.
Heiland T; Zeitschel U; Puchades MA; Kuhn PH; Lichtenthaler SF; Bjaalie JG; Hartlage-Rübsamen M; Roßner S; Höfling C
Glia; 2019 Feb; 67(2):393-403. PubMed ID: 30485540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
